2010
DOI: 10.3390/ijms11062499
|View full text |Cite
|
Sign up to set email alerts
|

Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings

Abstract: Probiotics are live microorganisms that promote health benefits upon consumption, while prebiotics are nondigestible food ingredients that selectively stimulate the growth of beneficial microorganisms in the gastrointestinal tract. Probiotics and/or prebiotics could be used as alternative supplements to exert health benefits, including cholesterol-lowering effects on humans. Past in vivo studies showed that the administration of probiotics and/or prebiotics are effective in improving lipid profiles, including … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

17
345
1
28

Year Published

2011
2011
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 591 publications
(391 citation statements)
references
References 109 publications
17
345
1
28
Order By: Relevance
“…2 Considering the mentioned reasons hypothesized by Ooi and Liong, 20 normolipidemic condition of used rat model in the current study may be a reason for failure of these probiotic bacteria in changing lipid profile. 20 In addition to all of the above, the feeding period of 30 days may not be sufficient to observe a significant change in lipid profile.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2 Considering the mentioned reasons hypothesized by Ooi and Liong, 20 normolipidemic condition of used rat model in the current study may be a reason for failure of these probiotic bacteria in changing lipid profile. 20 In addition to all of the above, the feeding period of 30 days may not be sufficient to observe a significant change in lipid profile.…”
Section: Discussionmentioning
confidence: 99%
“…[19][20][21] Ooi and Liong 20 in a review article attributed these controversial findings to various factors such as different strains of probiotics, administration dosage, analytical accuracy of lipid analyses, duration of treatment period, clinical characteristic of subjects, inadequate sample sizes, and lack of suitable controls or placebo groups. 2 Considering the mentioned reasons hypothesized by Ooi and Liong, 20 normolipidemic condition of used rat model in the current study may be a reason for failure of these probiotic bacteria in changing lipid profile. 20 In addition to all of the above, the feeding period of 30 days may not be sufficient to observe a significant change in lipid profile.…”
Section: Discussionmentioning
confidence: 99%
“…Acetate may act as a precursor for cholesterol synthesis, while propionate could inhibit hepatic cholesterol synthesis by decreasing the use of acetate as a precursor of cholesterol. 26 Also, inulin-type fructans may contribute to cholesterol reduction by increasing fecal bile acid excretion, reducing intestinal cholesterol absorption, as well as increasing of the expression of 3-hydroxy-3-methylglutaryl-COA reductase (HMG-COA reductase). 27 Their impact on TLR4 signaling and proinflammatory cytokines might be explaining the role of their lipid lowering.…”
Section: Discussionmentioning
confidence: 99%
“…Dysbiosis, resulting from an assault received from the long-term use of antibiotics, disease processes of the gastrointestinal tract such as Colon Carcinoma, Ulcerative colitis, IBS, Crohns Disease, Inflammatory Bowel Disease, Celiac Disease, and Traveler's Diarrhea, can leave the gut susceptible, and can benefit from its implementation. Research has supported probiotics to have antiinflammatory properties beneficial for the entire body, improve post menopausal symptoms, to address lactose intolerance, and to lower cholesterol levels [6], as one study stated by treating rats with L. plantarum with nanoparticle Tellurium, observed a reduction in the levels of the triglycerides [7].…”
Section: Probioticsmentioning
confidence: 99%